Back

Long-term outcomes following drug-coated balloons versus thin-strut drug-eluting stents for treatment of in-stent restenosis in chronic kidney failure

1 September 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Renal and cardiovascular disease (2) Renal Failure and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Rafal Januszek

Andrzej Frycz Modrzewski Krakow University, Krakow (Poland)

3 More presentations in this session

Presentation thumbnail
Direct healthcare costs for individuals with atherosclerotic cardiovascular disease, chronic kidney disease stages 3-4 or both: results from the UK Discover database
Doctor A. Thompson (London, GB)
Abstract Slides Video
Presentation thumbnail
Clinical profiles and echocardiographic changes of cardiac remodeling among kidney transplant patients
Doctor J. Cabrera (Metro Manila, PH)
Abstract Slides Video
Presentation thumbnail
Acute kidney injury in patients presenting with acute coronary syndrome, with and without diabetes mellitus
Doctor M. Shah (Hull, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Renal and cardiovascular disease (2)

The Event

Event poster

ESC Congress 2025

1 September 2025 14:15 CET
You may be interested in
thumbnail
Congress Session
Strategies and outcomes in in-stent restenosis
thumbnail
Congress Presentation
Long-term outcomes following DCB vs. DES for ISR treatment
thumbnail
Congress Presentation
Comparative outcomes of drug-coated balloon angioplasty versus second-generation drug-eluting stent for in-stent restenosis: a real-world data analysis

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources